PharmEasy in Advanced Talks to Acquire Thyrocare for Rs 7,000 crore: Report

The lack of a succession plan at Thyrocare could be a key reason for the company’s founder, Dr A Velumani, to sell the company, the report mentioned.

from Top Business News- News18.com https://ift.tt/2TFUQyA
via IFTTT